AGM update - withdrawal of Brett Wells director resolution
Filed with ASX · · 1 page · English
Summary by 6ix AI
Mayne Pharma Group Ltd. has announced the withdrawal of a director resolution for Dr. Brett Wells from its upcoming Annual General Meeting. This decision follows the company's recent announcement regarding a Scheme Implementation Deed with Gedeon Richter Plc. As a result, the resolution will not be presented to shareholders, but all other agenda items will proceed as planned.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Investor presentation re Scheme with Gedeon Richter
- MYX enters Scheme Implementation Deed with Gedeon Richter
- AGM updates
- Investor presentation re International segment divestment
- Mayne Pharma to divest International segment for $55.5m
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma